Thomas Joseph Gaven Jr. amazed his doctors for six years thanks to an innovative phase 1 clinical trial at Duke, finishing his earthly journey with GBM in February of 2021. He leaves behind a vibrant legacy of love and hope for his family and friends. Thank you for honoring Tom's beautiful life and spirit through this impactful fundraising effort-your support of Duke's innovative research endeavors, patients & families will help create a more hopeful world for the brain cancer survivors of tomorrow!